<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04749537</url>
  </required_header>
  <id_info>
    <org_study_id>IstPRMTRH-ASWP</org_study_id>
    <nct_id>NCT04749537</nct_id>
  </id_info>
  <brief_title>Work Productivity and Social Activities In Patients With Ankylosing Spondylitis</brief_title>
  <official_title>The Relationship Between The Decreasing Activity, Depression And Quality Of Life In Work Productivity And Social Activities In Ankylosing Spondylitis Patients: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the relationship between decrease in work productivity&#xD;
      and social activities in patients with Ankylosing Spondylitis (AS) with disease activity,&#xD;
      depression and quality of life together with demographic data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      For this study, which is planned as a cross-sectional clinical study, 100 patients who were&#xD;
      diagnosed with AS between the ages of 18-65 and who applied to the Istanbul Physical Therapy&#xD;
      Rehabilitation SUAM Physical Medicine and Rehabilitation Outpatient Clinic between April 15,&#xD;
      2019, and April 15, 2020, and 100 healthy volunteers compatible with age. was included.&#xD;
      Demographic data of the participants were recorded. Work productivity and activity reduction&#xD;
      questionnaire: general health (WPAI: GH), social role participation questionnaire short form&#xD;
      (SRPQ), short form-36 (SF-36), hospital anxiety, and depression scale (HADS), will be&#xD;
      evaluated. Besides, if the patient group exists, laboratory results (CRP, erythrocyte&#xD;
      sedimentation rate, HLA-B27), and bath ankylosing spondylitis functional index (BASFI), bath&#xD;
      ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis metrology&#xD;
      index (BASMI), visual analog scale (VAS) resting, night and activity values were recorded.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Actual">December 15, 2020</completion_date>
  <primary_completion_date type="Actual">April 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Work Productivity and Activity Impairment Questionnaire: General Health V2.0 (WPAI:GH)</measure>
    <time_frame>One day</time_frame>
    <description>WPAI: GH measures health impact and symptom severity impact on work productivity and leave time effectiveness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Social Role Participation Questionnaire (SRPQ)</measure>
    <time_frame>One day</time_frame>
    <description>It is used to evaluate integration into society and activities in social life. It evaluates the level of participation in six social roles in two dimensions: the &quot;experienced physical difficulties scale&quot; and the &quot;role performance satisfaction scale&quot;. Participants complete their satisfaction and challenges during their social roles</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short Form Health Survey 36 (SF-36)</measure>
    <time_frame>One day</time_frame>
    <description>used to evaluate the quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS)</measure>
    <time_frame>One day</time_frame>
    <description>used to determine the risk in terms of anxiety and depression in a patient with a physical illness, and to measure the level and change of severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)</measure>
    <time_frame>One day</time_frame>
    <description>the assessment of disease activity in patients with ankylosing spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bath Ankylosing Spondylitis Functional Index (BASFI)</measure>
    <time_frame>One day</time_frame>
    <description>the assessment of functional status in patients with ankylosing spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bath Ankylosing Spondylitis Metrology Index (BASMI)</measure>
    <time_frame>One day</time_frame>
    <description>the assessment of the level of spinal mobility in patients with ankylosing spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ankylosing Spondylitis Quality of Life (ASQoL)</measure>
    <time_frame>One day</time_frame>
    <description>used to evaluate the quality of life in patients with ankylosing spondylitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS)</measure>
    <time_frame>One day</time_frame>
    <description>used to evaluate the pain</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Ankylosing Spondylitis</condition>
  <condition>Work Productivity</condition>
  <arm_group>
    <arm_group_label>Ankylosing Spondylitis</arm_group_label>
    <description>100 patients who were diagnosed with AS between the ages of 18-65</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <description>100 healthy volunteers compatible with age.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        For this study, which is planned as a cross-sectional clinical study, 100 patients who were&#xD;
        diagnosed with AS between the ages of 18-65 and who applied to the Istanbul Physical&#xD;
        Therapy Rehabilitation SUAM Physical Medicine and Rehabilitation Outpatient Clinic between&#xD;
        April 15, 2019, and April 15, 2020, and 100 healthy volunteers compatible with age was&#xD;
        included.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with AS diagnosis between the ages of 18-65&#xD;
&#xD;
          -  Healthy volunteer individuals between the ages of 18-65 without known musculoskeletal&#xD;
             disease&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Those with serious systemic diseases that may interfere with working (respiratory&#xD;
             system, cardiovascular system, renal and metabolic diseases)&#xD;
&#xD;
          -  Those with orthopedic and psychiatric diseases&#xD;
&#xD;
          -  Those with inflammatory diseases other than known AS&#xD;
&#xD;
          -  Pregnant&#xD;
&#xD;
          -  People with disability due to the history of trauma&#xD;
&#xD;
          -  Those with injury after the operation&#xD;
&#xD;
          -  Those with diseases that cause neurological sequelae&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ömer Faruk Bucak, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Physical Medicine Rehabilitation Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Derya Bugdayci, Assoc Prof</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Macfarlane GJ, Shim J, Jones GT, Walker-Bone K, Pathan E, Dean LE. Identifying Persons with Axial Spondyloarthritis At Risk of Poor Work Outcome: Results from the British Society for Rheumatology Biologics Register. J Rheumatol. 2019 Feb;46(2):145-152. doi: 10.3899/jrheum.180477. Epub 2018 Nov 1. Erratum in: J Rheumatol. 2019 Jul;46(7):867-868.</citation>
    <PMID>30385702</PMID>
  </reference>
  <reference>
    <citation>Goh Y, Kwan YH, Leung YY, Fong W, Cheung PP. A cross-sectional study on factors associated with poor work outcomes in patients with axial spondyloarthritis in Singapore. Int J Rheum Dis. 2019 Nov;22(11):2001-2008. doi: 10.1111/1756-185X.13696. Epub 2019 Oct 1.</citation>
    <PMID>31576680</PMID>
  </reference>
  <reference>
    <citation>Sağ S, Nas K, Sağ MS, Tekeoğlu İ, Kamanlı A. Relationship of work disability between the disease activity, depression and quality of life in patients with ankylosing spondylitis. J Back Musculoskelet Rehabil. 2018;31(3):499-505. doi: 10.3233/BMR-169657.</citation>
    <PMID>29504521</PMID>
  </reference>
  <reference>
    <citation>van Lunteren M, Ez-Zaitouni Z, Fongen C, Landewé R, Ramonda R, van der Heijde D, van Gaalen FA. Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort). Rheumatology (Oxford). 2017 Dec 1;56(12):2222-2228. doi: 10.1093/rheumatology/kex365.</citation>
    <PMID>29155961</PMID>
  </reference>
  <reference>
    <citation>Oude Voshaar M, van Onna M, van Genderen S, van de Laar M, van der Heijde D, Heuft L, Spoorenberg A, Luime J, Gignac M, Boonen A. Development and Validation of a Short Form of the Social Role Participation Questionnaire in Patients with Ankylosing Spondylitis. J Rheumatol. 2016 Jul;43(7):1386-92. doi: 10.3899/jrheum.151013. Epub 2016 May 15.</citation>
    <PMID>27182067</PMID>
  </reference>
  <reference>
    <citation>van Genderen S, Plasqui G, Landewé R, Lacaille D, Arends S, van Gaalen F, van der Heijde D, Heuft L, Luime J, Spoorenberg A, Gignac M, Boonen A. Social Role Participation in Patients With Ankylosing Spondylitis: A Cross-Sectional Comparison With Population Controls. Arthritis Care Res (Hoboken). 2016 Dec;68(12):1899-1905. doi: 10.1002/acr.22907. Epub 2016 Oct 28.</citation>
    <PMID>27059161</PMID>
  </reference>
  <reference>
    <citation>Cakar E, Taskaynatan MA, Dincer U, Kiralp MZ, Durmus O, Ozgül A. Work disability in ankylosing spondylitis: differences among working and work-disabled patients. Clin Rheumatol. 2009 Nov;28(11):1309-14. doi: 10.1007/s10067-009-1249-1. Epub 2009 Aug 16.</citation>
    <PMID>19685294</PMID>
  </reference>
  <reference>
    <citation>Maksymowych WP, Gooch KL, Wong RL, Kupper H, van der Heijde D. Impact of age, sex, physical function, health-related quality of life, and treatment with adalimumab on work status and work productivity of patients with ankylosing spondylitis. J Rheumatol. 2010 Feb;37(2):385-92. doi: 10.3899/jrheum.090242. Epub 2009 Dec 1.</citation>
    <PMID>19955052</PMID>
  </reference>
  <reference>
    <citation>Deodhar AA, Dougados M, Baeten DL, Cheng-Chung Wei J, Geusens P, Readie A, Richards HB, Martin R, Porter B. Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1). Arthritis Rheumatol. 2016 Dec;68(12):2901-2910. doi: 10.1002/art.39805.</citation>
    <PMID>27390130</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 7, 2021</study_first_submitted>
  <study_first_submitted_qc>February 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>February 7, 2021</last_update_submitted>
  <last_update_submitted_qc>February 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spondylitis</keyword>
  <keyword>Ankylosing</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Employment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

